![](/img/cover-not-exists.png)
Comment on Udell et al. Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial. Diabetes Care 2015;38:696–705
Kalra, Sanjay, Gupta, Yashdeep, Baruah, Manash P., Gupta, AnuVolume:
38
Language:
english
Journal:
Diabetes Care
DOI:
10.2337/dc15-0006
Date:
June, 2015
File:
PDF, 980 KB
english, 2015